Table 3.
Hormones | Groups | |||||
---|---|---|---|---|---|---|
Male, (mean ± SEM) | Female, (mean ± SEM) | |||||
Non-diabetic Addicted (Case) | Non-diabetic Non-addicted (Control) | P-Value | Non-diabetic Addicted (Case) | Non-diabetic Non-addicted (Control) | P-Value | |
T3 (ng/dL) | 1.337±0.111 | 0.872±0.044 | 0.002* | 1.561±0.132 | 1.334±0.041 | 0.128 |
T4 (μg/dL) | 29.191±2.928 | 29.557±1.834 | 0.917 | 34.220±2.432 | 32.714±6.625 | 0.835 |
17OH-Progesterone (ng/mL) | 0.217±0.022 | 0.251±0.034 | 0.421 | 0.734±0.072 | 1.417±0.091 | < 0.001* |
Testosterone (ng/mL) | 0.261±0.034 | 0.351±0.037 | 0.104 | 0.617±0.041 | 0.242±0.029 | < 0.001* |
DHEA-S (ng/mL) | 0. 480±0.081 | 0.107±0.034 | 0.001* | 0.224±0.077 | 0.248±0.044 | 0.790 |
The Table 3 illustrates that in male non-diabetic addicted rats, the mean level of T3 had a significant increase in comparison with control group (P=0.002). However, the mean level of DHEA-S showed a significant decrease in non-diabetic addicted compared to non-diabetic non-addicted (P=0.001). Comparison of female non-diabetic non-addicted with non-diabetic addicted group, the mean levels of 17-hydroxyprogesterone and testosterone were significantly decreased and increased, respectively (P<0.001 for both comparisons). *Significance at 0.05 levels.